Related Experiment Video
Updated: May 5, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
On best practices: the Institute of Medicine scheme for developing, validating, and demonstrating clinical utility of
1Departments of Computational Medicine and Bioinformatics, Internal Medicine, and Human Genetics, School of Public Health, University of Michigan, Ann Arbor, MI, USA; Institute for Systems Biology, Seattle, WA, USA.
Abstract:
The Institute of Medicine of the US National Academy of Sciences issued a major report in 2012 that provides important guidance for the proteomics community for credible and transparent development of all kinds of omics-based diagnostic and prognostic tests. The key elements are summarized here to provide a compass that can guide the studies emerging from many laboratories as reported in this special issue of Proteomics Clinical Applications on "Diagnostic Proteomics."
Related Concept Videos
Automated Microbial Diagnostics
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Preclinical Development: Overview
In Vitro Drug Release Testing: Overview, Development and Validation

